NVDL | UBR | NVDL / UBR | |
Gain YTD | 7.561 | 64.177 | 12% |
Net Assets | 3.98B | 2.65M | 150,151% |
Total Expense Ratio | 1.06 | 0.95 | 112% |
Turnover | 11811.00 | N/A | - |
Yield | 0.00 | 4.46 | - |
Fund Existence | 3 years | 15 years | - |
NVDL | UBR | |
---|---|---|
RSI ODDS (%) | 2 days ago88% | 2 days ago89% |
Stochastic ODDS (%) | 2 days ago85% | 2 days ago87% |
Momentum ODDS (%) | 2 days ago90% | 2 days ago84% |
MACD ODDS (%) | 2 days ago90% | 2 days ago88% |
TrendWeek ODDS (%) | 2 days ago90% | 2 days ago88% |
TrendMonth ODDS (%) | 2 days ago90% | 2 days ago88% |
Advances ODDS (%) | 2 days ago90% | 2 days ago87% |
Declines ODDS (%) | N/A | N/A |
BollingerBands ODDS (%) | 2 days ago83% | 2 days ago85% |
Aroon ODDS (%) | 2 days ago90% | 2 days ago90% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SPYC | 42.50 | 1.11 | +2.69% |
Simplify US Equity PLUS Convexity ETF | |||
BST | 38.39 | 0.22 | +0.58% |
BlackRock Science and Technology Trust | |||
BGH | 15.75 | 0.02 | +0.13% |
Barings Global Short Duration High Yield Fund | |||
HELX | 28.05 | N/A | N/A |
Franklin Genomic Advancements ETF | |||
IBGA | 24.49 | -0.09 | -0.36% |
iShares iBonds Dec 2044 Term Trsy ETF |